News
TEL AVIV, Israel, April 9, 2025 /PRNewswire/ -- Biomed Israel, the premier international Life Science and HealthTech conference in Israel, will take place on May 20-22, 2025 at the David ...
announced that CEO Jonathan Solomon will present the company's promising Phase 2 trial results for BX211 at the Biomed Israel 2025 conference in Tel Aviv. BX211 targets diabetic foot infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results